Navigation Links
Cynosure Reports Record Revenues for Fourth-Quarter and Full-Year 2012
Date:2/12/2013

gation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including levels of demand for procedures performed with Cynosure products and for Cynosure products themselves, Cynosure's ability to maintain its profitability, competition in the aesthetic laser industry, general business and economic conditions, effects of acquisitions that Cynosure has made or may make, Cynosure's ability to develop and commercialize new products, Cynosure's reliance on sole source suppliers, the inability to accurately predict the timing or outcome of regulatory decisions, and economic, market, technological and other factors discussed in Cynosure's most recent Quarterly Report on Form 10-Q, which is filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, although Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.Timothy BakerScott SolomonExecutive VP, Treasurer and CFOVice President Cynosure, Inc. Sharon Merrill 978.256.4200617.542.5300TBaker@cynosure.comCYNO@investorrelations.com Consolidated Statements of Income (Unaudited)(In thousands, except per share data)Three Months Ended December 31,Year Ended December 31,2012201120122011Revenues$
42,669

$
34,102$
53,493

$
,602Cost of revenues 17,878

14,91564,567

48,294Gross profit24,791

19,18788,926

62
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cynosure Receives FDA Clearance for At-Home Device for the Treatment of Wrinkles
2. Cynosure Announces Upcoming Conference Presentations
3. Cynosure, Inc. Announces Proposed Public Offering of Class A Common Stock
4. Cynosure, Inc. Prices Public Offering of Class A Common Stock
5. Cynosure to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
6. Cynosure to Host Fourth-Quarter 2012 Financial Results Conference Call on February 12
7. Cynosure to Participate in Leerink Swann Global Healthcare Conference 2013
8. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
9. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
10. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
11. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 OpportunityAnalyzer: Cushing,s Syndrome - Opportunity ... GlobalData estimates that the 2013 sales for the ... across the 6MM covered in this report. Pharmaceutical ... time, and financial resources in the CS field, ... (R&D) strategies. One notable example is the fact ...
(Date:5/27/2015)... May 27, 2015 ... has announced the addition of the  "2015 ... Market"  report to their offering. ... issues pertaining to the US NAT laboratory ... demographic, social and technological trends with significant ...
(Date:5/27/2015)... Research and Markets ( ... the  "US Cancer Vaccine Market Outlook 2020" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,Cancer vaccines ... categories of prophylactic (preventive) and therapeutic (treatment) ... both of these groups have been marketed ...
Breaking Medicine Technology:OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 3OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 4United States Nucleic Acid Testing Market Strategies 2015-2020 2US Cancer Vaccine Market Outlook 2020 2US Cancer Vaccine Market Outlook 2020 3
... - Termination of Parkinson,s Disease Clinical Development and Focus ... Neuropathic Pain and Epilepsy ... is a first-in-class,orally administered, highly selective non-competitive AMPA-type glutamate,receptor ... disease, neuropathic pain, epilepsy, multiple,sclerosis and migraine prophylaxis., ...
... Napo,Pharmaceuticals, Inc., (LSE: NAPL and NAPU) is pleased ... Phase 2 trial for CRO-ID,(crofelemer for the treatment ... Glenmark Pharmaceuticals Limited (BSE: Glenmark). The,primary endpoints of ... frequency and stool consistency; additional endpoints followed,include degree ...
Cached Medicine Technology:Status of the E2007 (perampanel) Development Program 2Status of the E2007 (perampanel) Development Program 3Status of the E2007 (perampanel) Development Program 4Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 2Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 3Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 4Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 5
(Date:5/28/2015)... The second episode of “Extreme Weight Loss” Season ... need to transform their lives. Josh (29 years old) is ... deal with the death of his father. Kelli (26 years ... MO, who went into depression after her playing career ended. ... featured in one episode of “Extreme Weight Loss” on TUESDAY, ...
(Date:5/27/2015)... NJ (PRWEB) May 28, 2015 Throughout the ... study site for research comparing the validity and reliability of ... Dr. Preeti Nair, P.T., Ph.D., Associate Professor in the Department ... investigator for the study. , The Shaw Gait Assessment is ... piece of equipment. The GaitRite is considered the gold ...
(Date:5/27/2015)... Thermage was the first to come out ... in 2007 coinciding with the release of NXT or CPT, ... Precision Aesthetics was the first practice in New York to ... produced results that had never been achieved before non-surgically. ... still considered by many as the leading skin tightening device. ...
(Date:5/27/2015)... Ticket Down is a reputable source of 2015 ... currently in the middle of their series against the Anaheim Ducks ... If the Blackhawks can win tonight at home, this will tie ... 30th at the Honda Center in Anaheim. , During the ... Western Conference as they won the Pacific Division by 8 points ...
(Date:5/27/2015)... Ticket Down is a reputable source for 2015 Cleveland Cavaliers ... during the 2014-15 NBA season and they delighted their fan base ... of 118-88. , For the Cavaliers, this is their ... lost to the San Antonio Spurs. Once Lebron James joined ... it to the NBA finals increased tenfold. The team had ...
Breaking Medicine News(10 mins):Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 3Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:Non-Surgical Fat Reduction and Skin Tightening Procedures, Thermage and Exilis, Increase 200% at Precision Aesthetics in New York, April 2015 2Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:Cavs NBA Finals Tickets: Ticket Down Slashes Ticket Prices on Cleveland Cavaliers 2015 NBA Finals Tickets at Quicken Loans Arena and Offers Valuable Promo Code 2
... could boost death risk, researchers say , , TUESDAY, ... men at high risk for cardiovascular disease, diabetes and ... the odds, according to new studies. , Some ... common with age, are linked to several health conditions. ...
... to the public, agency says , , TUESDAY, June 17 (HealthDay ... letters warning more than two dozen companies to stop selling ... The agency is also cautioning consumers not to buy or ... and creams, and are sold under various names on the ...
... Labs That Are Looking to Place Strategic Bets for the ... ... /Xinhua-PRNewswire/ -- Singapore,s investment of,more than US$2.1 billion in the biomedical sciences ... spending in the,biomedical sciences grew by more than 24% to reach US$760 ...
... Many Have Changed to Health Care & Economic Security ... SPRINGFIELD, Ill., June 17 150 years ago,this ... the,Illinois State Capitol in Springfield. AARP Illinois took the ... issues have changed,the problems of division preventing progress on ...
... Health,Insurance Plans (AHIP) today announced a new ... information technology company, to assist,health insurance plans ... consumers., "This partnership reflects our industry,s ... Health Records," said Charles,Stellar, Executive Vice President ...
... Health,Services, Inc. (Nasdaq: GTIV ), the nation,s leading ... is scheduled to,present from 1:00 to 1:30 p.m. ET, ... Conference in New York., The presentation will be ... which may be accessed by visiting, http://investors.gentiva.com/events.cfm to ...
Cached Medicine News:Health News:Studies Support Testosterone Supplements for Older Men 2Health News:FDA Warns Companies to Stop Selling Fake Cancer Cures 2Health News:FDA Warns Companies to Stop Selling Fake Cancer Cures 3Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 2Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 3Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 4Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 5Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 6Health News:150 Years Later 'House Divided' Speech Still Holds Strong Message 2Health News:AHIP Selects HealthTrio to Join AHIP Solutions Program 2Health News:Gentiva(R) Health Services to Present June 24 at Jefferies' 2nd Annual Healthcare Conference in New York 2Health News:Gentiva(R) Health Services to Present June 24 at Jefferies' 2nd Annual Healthcare Conference in New York 3
...
...
...
Tip is bent towards port for downward irrigation. 25G x 5/8in (.50 x 22mm)...
Medicine Products: